Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules

被引:114
作者
Oehninger, Luciano [1 ]
Stefanopoulou, Maria [2 ]
Alborzinia, Hamed [3 ]
Schur, Julia [1 ]
Ludewig, Stephanie [1 ]
Namikawa, Kazuhiko [4 ]
Munoz-Castro, Alvaro [5 ]
Koester, Reinhard W. [4 ]
Baumann, Knut [1 ]
Woelfl, Stefan [3 ]
Sheldrick, William S. [2 ]
Ott, Ingo [1 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmaceut Chem, D-38106 Braunschweig, Germany
[2] Ruhr Univ Bochum, Lehrstuhl Analyt Chem, D-44780 Bochum, Germany
[3] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
[4] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cell Biol & Cell Physiol, D-38106 Braunschweig, Germany
[5] Univ Andres Bello, Dept Chem Sci, Santiago 275, Chile
关键词
THIOREDOXIN REDUCTASE; ANTICANCER ACTIVITY; GOLD(I) COMPLEXES; IN-VITRO; BINDING; INHIBITION; ACTIVATION; CELLS;
D O I
10.1039/c2dt32319b
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Metal complexes with N-heterocyclic carbene (NHC) ligands have been widely used in catalytic chemistry and are now increasingly considered for the development of new chemical tools and metal based drugs. Ruthenium complexes of the type (p-cymene)(NHC)RuCl2 interacted with biologically relevant thiols and selenols, which resulted in the inhibition of enzymes such as thioredoxin reductase or cathepsin B. Pronounced antiproliferative effects could be obtained provided that an appropriate cellular uptake was achieved. Inhibition of tumor cell growth was accompanied by a perturbation of metabolic parameters such as cellular respiration.
引用
收藏
页码:1657 / 1666
页数:10
相关论文
共 51 条
[1]   Real-Time Monitoring of Cisplatin-Induced Cell Death [J].
Alborzinia, Hamed ;
Can, Suzan ;
Holenya, Pavlo ;
Scholl, Catharina ;
Lederer, Elke ;
Kitanovic, Igor ;
Woelfl, Stefan .
PLOS ONE, 2011, 6 (05)
[2]   Biomedical Properties of a Series of Ruthenium-N-Heterocyclic Carbene Complexes Based on Oxidant Activity In Vitro and Assessment In Vivo of Biosafety in Zebrafish Embryos [J].
Alfaro, Juan M. ;
Prades, Amparo ;
del Carmen Ramos, Maria ;
Peris, Eduardo ;
Ripoll-Gomez, Jorge ;
Poyatos, Macarena ;
Burgos, Javier S. .
ZEBRAFISH, 2010, 7 (01) :13-21
[3]   Organometallic ruthenium-based antitumor compounds with novel modes of action [J].
Ang, Wee Han ;
Casini, Angela ;
Sava, Gianni ;
Dyson, Paul J. .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2011, 696 (05) :989-998
[4]  
[Anonymous], 2012, AMST DENS FUNCT ADF
[5]  
[Anonymous], 2010, ANGEW CHEM INT EDIT
[6]   Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents [J].
Barnard, PJ ;
Baker, MV ;
Berners-Price, SJ ;
Day, DA .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2004, 98 (10) :1642-1647
[7]   (ETA-6-HEXAMETHYLBENZENE)RUTHENIUM COMPLEXES [J].
BENNETT, MA ;
HUANG, TN ;
MATHESON, TW ;
SMITH, AK .
INORGANIC SYNTHESES, 1982, 21 :74-78
[8]   Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs [J].
Bergamo, Alberta ;
Sava, Gianni .
DALTON TRANSACTIONS, 2011, 40 (31) :7817-7823
[9]   Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium (II)-Arene Compounds [J].
Casini, Angela ;
Gabbiani, Chiara ;
Sorrentino, Francesca ;
Rigobello, Maria Pia ;
Bindoli, Alberto ;
Geldbach, Tifimann J. ;
Marrone, Alessandro ;
Re, Nazzareno ;
Hartinger, Christian G. ;
Dyson, Paul J. ;
Messori, Luigi .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) :6773-6781
[10]   ESI-MS characterisation of protein adducts of anticancer ruthenium(II)-arene PTA (RAPTA) complexes [J].
Casini, Angela ;
Mastrobuoni, Guido ;
Ang, Wee Han ;
Gabbiani, Chiara ;
Pieraccini, Giuseppe ;
Moneti, Gloriano ;
Dyson, Paul J. ;
Messori, Luigi .
CHEMMEDCHEM, 2007, 2 (05) :631-+